NASDAQ:VIR

Vir Biotechnology Stock Insider Trading

etoro logo Buy VIR
*Your capital is at risk
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026

Vir Biotechnology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -80.40. In total, the insiders bought 1.9M and sold 5.09M VIR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-80.40
Buy 1.9M shares
Sell 5.09M shares
27% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
Apr 29, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -80.4.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Sell
Common Stock
S-Sale
Sabatini Brent
SVP, Chief Accounting Officer
Officer 379
Value: $4K
Jun 01, 2026
Sell
Common Stock
S-Sale
Napolitano Janet
Director
Director 3 200
Value: $30.2K
May 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Farid Ramy
Director
Director 16 000
Value: $145.6K
May 27, 2026
Buy
Common Stock
A-Award
Farid Ramy
Director
Director 8 000
Value: $72.8K
May 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Hatfield Jeffrey S.
Director
Director 16 000
Value: $145.6K
May 27, 2026
Buy
Common Stock
A-Award
Hatfield Jeffrey S.
Director
Director 8 000
Value: $72.8K
May 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
More Robert J
Director
Director 16 000
Value: $145.6K
May 27, 2026
Buy
Common Stock
A-Award
More Robert J
Director
Director 8 000
Value: $72.8K
May 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Napolitano Janet
Director
Director 16 000
Value: $145.6K
May 27, 2026
Buy
Common Stock
A-Award
Napolitano Janet
Director
Director 8 000
Value: $72.8K
May 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Sigal Charles Elliott
Director
Director 16 000
Value: $145.6K
May 27, 2026
Buy
Common Stock
A-Award
Sigal Charles Elliott
Director
Director 8 000
Value: $72.8K
May 27, 2026
Buy
Common Stock
A-Award
Bischofberger Norbert W
Director
Director 8 000
Value: $72.8K
May 27, 2026
Buy
Stock Option (Right to Buy)
A-Award
Bischofberger Norbert W
Director
Director 16 000
Value: $145.6K
May 01, 2026
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 22 000
Value: $221.0K
Apr 29, 2026
Buy
Common Stock
J-Other
De Backer Marianne
President And CEO
CEO / President 233 532
Value: $2.35M
Apr 29, 2026
Sell
Common Stock
J-Other
De Backer Marianne
President And CEO
CEO / President 233 532
Value: $0
Apr 06, 2026
Sell
Common Stock
S-Sale
De Backer Marianne
President And CEO
CEO / President 72 559
Value: $664.4K
Apr 01, 2026
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 22 000
Value: $199.6K
Mar 23, 2026
Sell
Common Stock
S-Sale
Sabatini Brent
SVP, Chief Accounting Officer
Officer 7 711
Value: $70.3K
Mar 20, 2026
Buy
Common Stock
J-Other
O'byrne Jason
EVP & Chief Financial Officer
C-Suite Officer 2 500
Value: $22.8K
Mar 20, 2026
Sell
Common Stock
J-Other
O'byrne Jason
EVP & Chief Financial Officer
C-Suite Officer 2 500
Value: $0
Mar 02, 2026
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 21 800
Value: $207.2K
Mar 02, 2026
Sell
Common Stock
S-Sale
Sato Vicki L
Director
Director 200
Value: $2K
Feb 25, 2026
Sell
Common Stock
S-Sale
Eisner Mark
EVP And Chief Medical Officer
Officer 1 889
Value: $18.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VIR BIOTECHNOLOGY, INC.
Vir Biotechnology
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE